BR0004709A - Derivados de quinolin-4-ila ii - Google Patents

Derivados de quinolin-4-ila ii

Info

Publication number
BR0004709A
BR0004709A BR0004709-0A BR0004709A BR0004709A BR 0004709 A BR0004709 A BR 0004709A BR 0004709 A BR0004709 A BR 0004709A BR 0004709 A BR0004709 A BR 0004709A
Authority
BR
Brazil
Prior art keywords
lower alkyl
amino
hydrogen
ila
quinolin
Prior art date
Application number
BR0004709-0A
Other languages
English (en)
Inventor
Alexander Alanine
Serge Burner
Bernd Buettelmann
Marie-Paule Heitz Neidhart
Georg Jaeschke
Emmanuel Pinard
Rene Wyler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR0004709A publication Critical patent/BR0004709A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Patente de Invenção: <B>"DERIVADOS DE QUINOLIN-4-ILA II"<D>. A presente invenção refere-se a compostos da fórmula genérica onde R¹ é hidrogênio, alquila inferior, alcóxi inferior, hidróxi, amino, nitro, ciano, amino - alquila inferior, amino - alquila di - inferior ou halogênio; R² é hidrogênio, alquila inferior, amino, pirrolidin-3-ol, pirrolidin-2-ila, metanol ou -NHCH~ 2~CHROH; R³ é hidrogênio ou halogênio; R é hidrogênio, alquila inferior ou -CH~ 2~OH; n é 1 ou 2; e a seus sais de adição ácidos farmaceuticamente aceitáveis. Compostos da presente invenção são bloqueadores seletivos do subtipo receptor-NMDA(N-metil-D-aspartato), que têm uma função chave em modulação de atividade e plasticidade neuronal em processos de mediação subjacentes ao desenvolvimento de CNS assim como aprendizado e formação de memória.
BR0004709-0A 1999-10-08 2000-10-06 Derivados de quinolin-4-ila ii BR0004709A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99120131 1999-10-08

Publications (1)

Publication Number Publication Date
BR0004709A true BR0004709A (pt) 2001-06-12

Family

ID=8239160

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0004709-0A BR0004709A (pt) 1999-10-08 2000-10-06 Derivados de quinolin-4-ila ii

Country Status (26)

Country Link
US (1) US6339093B1 (pt)
EP (1) EP1090917B1 (pt)
JP (1) JP3385318B2 (pt)
KR (1) KR100398562B1 (pt)
CN (1) CN1162424C (pt)
AR (1) AR032601A1 (pt)
AT (1) ATE313538T1 (pt)
AU (1) AU777881B2 (pt)
BR (1) BR0004709A (pt)
CA (1) CA2322309C (pt)
DE (1) DE60024947T2 (pt)
DK (1) DK1090917T3 (pt)
EG (1) EG23872A (pt)
ES (1) ES2254095T3 (pt)
HR (1) HRP20000652A2 (pt)
HU (1) HUP0003938A2 (pt)
ID (1) ID27526A (pt)
IL (1) IL138916A0 (pt)
MA (1) MA26753A1 (pt)
MX (1) MXPA00009771A (pt)
NO (1) NO20005031L (pt)
NZ (1) NZ507303A (pt)
PE (1) PE20010660A1 (pt)
PL (1) PL343057A1 (pt)
TR (1) TR200002893A2 (pt)
ZA (1) ZA200005447B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339093B1 (en) * 1999-10-08 2002-01-15 Hoffmann-La Roche Inc. Isoquinoline derivatives
JP2005506292A (ja) * 2001-03-08 2005-03-03 エモリー　ユニバーシティ ｐＨに依存するＮＭＤＡレセプターアンタゴニスト
US6831087B2 (en) 2001-11-09 2004-12-14 Hoffmann-La Roche Inc. Pyridine substituted isoquinoline derivatives
US7005432B2 (en) * 2002-05-16 2006-02-28 Hoffman-La Roche Inc. Substituted imidazol-pyridazine derivatives
US8110681B2 (en) 2006-03-17 2012-02-07 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Compounds for the treatment of spinal muscular atrophy and other uses
NZ581853A (en) * 2007-06-18 2012-11-30 Richter Gedeon Nyrt Sulfonyl-quinoline derivatives
CN103058957A (zh) 2007-06-29 2013-04-24 埃莫里大学 用于神经保护的nmda受体拮抗剂
CA2700841A1 (en) * 2007-09-27 2009-04-02 The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
US9938269B2 (en) 2011-06-30 2018-04-10 Abbvie Inc. Inhibitor compounds of phosphodiesterase type 10A
DK3452465T3 (da) * 2016-05-04 2021-02-08 Genoscience Pharma Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme
US11274107B2 (en) 2016-12-22 2022-03-15 Cadent Therapeutics, Inc. NMDA receptor modulators and uses thereof
EA202190431A1 (ru) 2018-08-03 2021-06-11 Кэйдент Терапьютикс, Инк. Гетероароматические модуляторы nmda рецептора и их применение

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8409745D0 (en) * 1984-04-14 1984-05-23 Beecham Group Plc Active compounds
US4560692A (en) * 1984-07-18 1985-12-24 Hoffmann-La Roche Inc. 4-Piperidino-2-phenylquinolines
GB8716972D0 (en) * 1987-07-17 1987-08-26 Pfizer Ltd Treatment of cardiac arrhythmias
JPH0262875A (ja) 1988-05-23 1990-03-02 Wakunaga Pharmaceut Co Ltd 新規イソインドリン誘導体
US4992448A (en) * 1989-10-24 1991-02-12 Hoechst-Roussel Pharmaceuticals Inc. Benzocycloalkylaminopyridinamines and related compounds as topical antiinflammatory agents for the treatment of skin disorders
US5304554A (en) * 1990-04-27 1994-04-19 Emory University 4-[(alkyl or dialkyl)amino]quinolines and their method of preparation
GB9203798D0 (en) * 1992-02-21 1992-04-08 Fujisawa Pharmaceutical Co Quinolylbenzofuran derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
GB9305644D0 (en) * 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents
US5567718A (en) * 1994-08-11 1996-10-22 Hoechst Marion Roussel Inc. 2,3-dihydro-1h-isoindole derivatives and their use as serotonin reuptake inhibitors
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
US6339093B1 (en) * 1999-10-08 2002-01-15 Hoffmann-La Roche Inc. Isoquinoline derivatives

Also Published As

Publication number Publication date
DK1090917T3 (da) 2006-04-24
NO20005031L (no) 2001-04-09
EP1090917A1 (en) 2001-04-11
ZA200005447B (en) 2001-04-09
MXPA00009771A (es) 2002-10-23
US6339093B1 (en) 2002-01-15
MA26753A1 (fr) 2004-12-20
HU0003938D0 (en) 2000-12-28
HRP20000652A2 (en) 2001-12-31
CN1304936A (zh) 2001-07-25
ID27526A (id) 2001-04-12
EG23872A (en) 2007-11-27
DE60024947D1 (de) 2006-01-26
PE20010660A1 (es) 2001-06-26
AU6410000A (en) 2001-04-12
DE60024947T2 (de) 2006-09-21
HUP0003938A2 (hu) 2002-11-28
CA2322309A1 (en) 2001-04-08
ATE313538T1 (de) 2006-01-15
CN1162424C (zh) 2004-08-18
PL343057A1 (en) 2001-04-09
EP1090917B1 (en) 2005-12-21
KR100398562B1 (ko) 2003-09-19
JP3385318B2 (ja) 2003-03-10
IL138916A0 (en) 2001-11-25
AU777881B2 (en) 2004-11-04
JP2001114777A (ja) 2001-04-24
AR032601A1 (es) 2003-11-19
TR200002893A3 (tr) 2001-04-20
NZ507303A (en) 2002-09-27
KR20010050915A (ko) 2001-06-25
NO20005031D0 (no) 2000-10-06
CA2322309C (en) 2008-05-20
ES2254095T3 (es) 2006-06-16
TR200002893A2 (tr) 2001-04-20

Similar Documents

Publication Publication Date Title
BR0004709A (pt) Derivados de quinolin-4-ila ii
BRPI0409255A (pt) derivados de ácido 2-(8,9-dioxo-2,6-diazabi-ciclo(5.2.0)non-1(7)-en-2-il)alquil fosfÈnico e seu uso como antagonistas de receptores de d-asparto de -n-metila (nmda)
BR0113629A (pt) Inibidores da adesão celular mediada por alfa4
GB2369360A (en) 5-cyano-2-aminopyrimidine derivatives
ATE302205T1 (de) Thieno- und furopyrimidin derivate als a2a- rezeptor antagonisten
NO20052989D0 (no) Terapeutiske forbindelser.
BRPI0518581A2 (pt) compostos de cromanilurÉia que inibem o receptor do subtipo 1 do recepetor vanilàide (vr1) e usos destes
CO5280078A1 (es) Compuestos
BR9916781A (pt) 4-oxo-1,4-dihidro-3-quinolinacarboxamidas comoagentes antivirais
BR0115609A (pt) Agentes serotonérgicos
TR200102489T2 (tr) 3-Fenilpiridin Türevleri ve bunların NK-1 alıcı antagonistler olarak kullanılması
MX2008013040A (es) Derivados de bencimidazol 5-sulfonamida como ligandos del receptor cannabinoide 1.
BR9916318A (pt) Compostos bicìclicos
WO2000012482A3 (en) Indazole derivatives with 5-ht2 receptor activity
BR0307027A (pt) Compostos derivados de nitróxi de compostos esteróides, uso dos compostos, e, formulações farmacêuticas
BR0311410A (pt) Composto de piperidina
PT1189923E (pt) Derivados aromaticos e heterociclicos de fitosterois e/ ou fitostanois para utilizacao no tratamento ou prevencao de doenca cardiovascular
WO2001010860A3 (en) Quinazolinone and azaquinazolinone derivatives
BR0015333A (pt) Derivados de isoxazol como inibidores de fosfodiesterase vii
BR0209604A (pt) Derivados de 1-oxa-3,9-diaza-spiro-5,5-undecan-2-onas e seu uso como antagonista do receptor para neuricinina
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
DK1136475T3 (da) Piperidin- og piperazinderivater til anvendelse i behandlingen af Alzheimer
BR9705509A (pt) Deivados de 4-hidroxi-piperidina.
BR0113348A (pt) Pró-drogas para ligantes de receptores de nmda
BR0315809A (pt) Derivados de piperazina substituìdos com oxindol

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements